XTRA:DRW3Medical Equipment
Is Drägerwerk KGaA (XTRA:DRW3) Undervalued As Q2 Earnings Lift Sales And Net Income?
Why Drägerwerk KGaA Stock Is In Focus After Q2 Earnings
Drägerwerk KGaA (XTRA:DRW3) is back on investor radar after its second quarter 2026 earnings, with sales of €847.31 million and net income of €29.52 million reported for the period.
For the first six months to June 30, 2026, Drägerwerk KGaA reported sales of €1,603.18 million and net income of €40.95 million, compared with the same metrics a year earlier.
See our latest analysis for Drägerwerk KGaA.
The Q2 update has arrived after a...